![Stuart Poulton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 181 693 $ in data 31/07/2026
Stuart Poulton is Chief Development Officer & Executive VP at Karyopharm Therapeutics, Inc. since 2022.
Formerly, Mr. Poulton was Vice President-Clinical Development Operations at AbbVie, Inc. from 2019 to 2022, Executive Director-Global Program Management at Amgen, Inc. from 2013 to 2016, and Head-Clinical Operations at Eli Lilly & Co. Education includes graduate studies at The University of New South Wales and undergraduate studies at The University of Sydney.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 28/07/2026 | 94.632 ( 0,42% ) | 181 693 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Corporate Officer/Principal | 01/02/2022 |
| Società | Posizione | Fine |
|---|---|---|
| ABBVIE INC. | Corporate Officer/Principal | 01/01/2022 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2016 |
| ELI LILLY AND COMPANY | Direttore Tecnico/Scientifico/R&S | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
The University of New South Wales
 The University of New South Wales Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Sydney
 The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karyopharm Therapeutics, Inc.
 Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
